Shukra Pharmaceuticals P/B Ratio
Shukra Pharmaceuticals (SHUKRAPHAR) P/B ratio is 135.36 (High), book value per share ₹14.32 vs Healthcare average P/B of -0.19 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see SHUKRAPHAR share price.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
SHUKRAPHAR P/B Ratio — Valuation Insights & Book Value Analysis
Shukra Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 135.36 (High). Check SHUKRAPHAR market value to track the company's total market size over time.
- Stock appears overvalued with PB of 135.36, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 15040.9% above historical average
- Trading at premium to sector average PB of -0.19
Shukra Pharmaceuticals P/B Ratio Historical Trend
SHUKRAPHAR annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Also explore SHUKRAPHAR stock price history to track price trends across different timeframes.
SHUKRAPHAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Shukra Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 4.14 | ₹14.32 | ₹59.25 | ₹63 | High |
| 2024 | 0.26 | ₹52.73 | ₹13.65 | ₹58 | Low |
| 2023 | 0.05 | ₹62.5 | ₹3.10 | ₹25 | Low |
| 2022 | 0.01 | ₹80.0 | ₹0.70 | ₹16 | Low |
| 2021 | 0.01 | ₹80.0 | ₹0.45 | ₹16 | Low |
SHUKRAPHAR vs Healthcare Peers — P/B Ratio Comparison
Shukra Pharmaceuticals P/B 135.36 vs Healthcare average -0.19, median 0.67 — range -13.75–1.07.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -13.75 | ₹4,814 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |